GNMSF:OTCMKTS
Genmab A/S
367,00 USD
0,00%
(0,00) 1D
9-окт., 10:28:36 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Mkt. cap
22,76 млд
Avg. vol.
1,37 миң
Volume
180,00
52-wk high
396,97 USD
52-wk low
232,50 USD
Beta
0,73
Shares outstanding
62,41 млн
No. of employees
3 миң
Mkt. cap
22,76 млд
Avg. vol.
1,37 миң
Volume
180,00
52-wk high
396,97 USD
52-wk low
232,50 USD
Beta
0,73
Shares outstanding
62,41 млн
No. of employees
3 миң
News stories
From web sources and news partners
TipRanks
·
1 күн мурун
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3,12 миң
Founded1998-ж., 11-июн.
Headquarters-
Sector-
Websitegenmab.com